Top Markets
Coin of the day
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
주식 순위 #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
주가
$0.00001
시가총액
$50.01K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 MultiCell Technologies, Inc. (MCET)

카테고리

MultiCell Technologies, Inc. (MCET)의 P/S 비율
March 2026 기준 P/S 비율 TTM: 1.01K
MultiCell Technologies, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 1.01K입니다. 2013년 말 기준 P/S 비율은 27.21였습니다.
MultiCell Technologies, Inc.의 P/S 비율 기록 (2013 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 1.01K 3,255.43%
2014 30.22 11.07%
2013 27.21 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
3.55 -99.65%
DK
9.90 -99.02%
US
5.40 -99.47%
US
6.14 -99.39%
BE
3.04 -99.70%
AU